|
In late-stage study, Novartis finds asthma drug effective at reducing itch …
MedCity News ZURICH (Reuters) – Swiss drugmaker Novartis said on Saturday its drug omalizumab was almost doubly effective in improving quality of life for patients with a severe form of hives, compared with a placebo, according to a late-stage study. The third and … |
View full post on asthma – Google News